Fatty liver disease was not associated with Parkinsonism or Parkinson's disease in an elderly European population, the Rotterdam Study, (n = 8.848), neither in men nor women. Results were consistent either using non-alcoholic fatty liver disease (NAFLD) or metabolic-dysfunction associated fatty liver disease (MAFLD) as exposure defined by either fatty liver index (FLI) or ultrasound.
|Journal||Parkinsonism and Related Disorders|
|Early online date||30 Nov 2022|
|Publication status||Published - 1 Jan 2023|
Bibliographical noteFunding Information: The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam , Netherlands Organization for the Health Research and Development (ZonMw) , t he Research institute for Diseases in the Elderly (Ride) , the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports , the European Commission (DG XII) and the Municipality of Rotterdam . Further funding was obtained through the Stichting Erasmus Trustfonds , grant number 97030.2021.101.430/057/RB . Financial support was also provided by the Foundation for Liver and Gastrointestinal Research, Rotterdam, the Netherlands . The funding sources did not influence study design, data collection, analysis and interpretation of the data, nor the writing of the report and decision to submit for publication.
Publisher Copyright: © 2022 Elsevier Ltd